Pharmacology and Anatomy in Cardiology

Anatomy of the Heart

  • Discussion of heart anatomy not covered during this session.

Medications in Cardiology

Overview
  • Mention of the importance of specific slides in the perfusion lecture:

    • Slide 35: Beta Blockers

    • Slide 36: RAAS Blockers

    • Slide 37: Vasodilators and Cardiac Agents

    • Slide 43: Statins and Lipid-Lowering Drugs

    • Slide 61: Anticoagulants

  • Advisement to review slides for exam preparation.

Beta Blockers (Slide 35)
  • Definitions:

    • Selective Beta Blockers: Act primarily on the heart (e.g., metoprolol).

    • Nonselective Beta Blockers: Act on both heart and lungs, can impair lung function (e.g., bronchoconstriction).

  • Nursing Considerations:

    • Monitor heart rate and systolic blood pressure before administration.

    • Hold if heart rate < 60 BPM or systolic BP < 100 mmHg.

    • Do not stop abruptly.

  • Clinical Considerations:

    • Nonselective beta blockers should not be given to patients with asthma or COPD due to potential bronchoconstriction.

Clonidine (Slide 35)
  • Definition: Alpha-2 agonist.

  • Caution against abrupt discontinuation.

Calcium Channel Blockers (Slide 35)
  • Mechanism of Action: Reduces calcium influx, causing smooth muscle relaxation.

  • Adverse Effects:

    • Can cause edema, specifically lower extremity edema due to vasodilation.

  • Example: Amlodipine.

  • Nursing Considerations: Monitor blood pressure and heart rate.

Diuretics (Slide 35)
  • Nursing Considerations:

    • Monitor potassium levels.

    • Administer in the morning to avoid nocturia.

RAAS Blockers (Slide 36)
  • Types: ACE inhibitors and ARBs.

  • Monitoring:

    • Potassium and blood pressure monitoring.

  • ACEs can cause angioedema; transition to ARBs if this occurs.

  • Mechanism of Action:

    • ACE inhibitors prevent conversion of angiotensin I to angiotensin II.

    • ARBs block the receptor sites of angiotensin II.

Vasodilators and Cardiac Agents (Slide 37)
  • Notable Drugs: Digoxin and nitroglycerin.

  • Important Concepts: Understand preload and afterload.

  • Digoxin toxicity: Hypokalemia increases risk; monitor signs of toxicity and hold if apical heart rate < 60.

Statins and Lipid-Lowering Drugs (Slide 43)
  • Mechanism of Action: Block LDL production in the liver.

  • Considerations:

    • Administer at bedtime (except for some).

    • Monitor liver function tests.

    • Caution with grapefruit juice.

Fibrates
  • Example: Gemfibrozil.

  • Mechanism: Primarily affects triglycerides and can raise HDL.

  • Nursing Considerations: Monitor liver function and myopathy risks.

Niacin
  • Increases HDL but can cause flushing; premedicate with aspirin to reduce flushing.

Anticoagulants (Slide 61)
  • Types: Familiarize with Direct Oral Anticoagulants (DOACs) and differences from warfarin and heparin.

  • Monitoring for Heparin:

    • Watch for heparin-induced thrombocytopenia (HIT); platelet counts should be monitored.

Peripheral Arterial Disease (PAD) vs. Venous Disease

PAD
  • Clinical Presentation: Symptoms include intermittent claudication, pallor, and diminished pulses.

  • Patient Positioning: Legs down to promote blood flow.

  • Management Goals: Encourage walking to promote collateral circulation despite pain.

Venous Insufficiency
  • Clinical signs differ from PAD; often presents with swelling and discoloration.

Aneurysms

Aortic Aneurysm and Dissection
  • Aneurysms: Weakening of the vessel wall.

    • Types: Aortic dissection vs. abdominal aortic aneurysm (AAA).

    • Ruptured AAA: High mortality risk; prompt identification and treatment required.

  • Signs and Symptoms in Dissection: Sudden ripping or tearing pain, often in the chest or back.

  • Management: Aggressive blood pressure control; IV antihypertensives may be initiated.

Congenital Heart Defects

Key Concepts and Terminology
  • Cyanotic vs. Acyanotic:

    • Cyanotic: Poor oxygenation, typically affecting blood flow to the lungs (e.g., Tetralogy of Fallot).

    • Acyanotic: Adequate oxygenation.

Tetralogy of Fallot
  • Defects:

    • Ventricular septal defect, pulmonary stenosis, right ventricular hypertrophy, and aorta positioned over both ventricles.

  • Management: Need for patent ductus arteriosus to maintain blood flow to lungs, which can be maintained with medications (e.g. prostaglandins).

EKG Interpretation and Cardiac Rhythms

Basic Interpretations
  • Sinus Bradycardia and Sinus Tachycardia: Distinction is made based on heart rate and symptoms.

  • Atrial Fibrillation: Unorganized rhythm; patient may show risk for clotting due to stasis in the atrium.

  • Ventricular Tachycardia: Two classifications based on the presence of a pulse; interventions differ accordingly.

STEMI
  • Definition: ST-elevation myocardial infarction signaling potential myocardial injury.

Summary

  • Constant emphasis on understanding underlying mechanisms and nursing considerations for various medications and clinical conditions. Encourage continuous revision and engagement with provided content for successful examination outcomes.